Literature DB >> 28490596

Deletion of the Vaccinia Virus I2 Protein Interrupts Virion Morphogenesis, Leading to Retention of the Scaffold Protein and Mislocalization of Membrane-Associated Entry Proteins.

Seong-In Hyun1,2, Andrea Weisberg1, Bernard Moss3.   

Abstract

The I2L open reading frame of vaccinia virus (VACV) encodes a conserved 72-amino-acid protein with a putative C-terminal transmembrane domain. Previous studies with a tetracycline-inducible mutant demonstrated that I2-deficient virions are defective in cell entry. The purpose of the present study was to determine the step of replication or entry that is affected by loss of the I2 protein. Fluorescence microscopy experiments showed that I2 colocalized with a major membrane protein of immature and mature virions. We generated a cell line that constitutively expressed I2 and allowed construction of the VACV I2L deletion mutant vΔI2. As anticipated, vΔI2 was unable to replicate in cells that did not express I2. Unexpectedly, morphogenesis was interrupted at a stage after immature virion formation, resulting in the accumulation of dense spherical particles instead of brick-shaped mature virions with well-defined core structures. The abnormal particles retained the D13 scaffold protein of immature virions, were severely deficient in the transmembrane proteins that comprise the entry fusion complex (EFC), and had increased amounts of unprocessed membrane and core proteins. Total lysates of cells infected with vΔI2 also had diminished EFC proteins due to instability attributed to their hydrophobicity and failure to be inserted into viral membranes. A similar instability of EFC proteins had previously been found with unrelated mutants blocked earlier in morphogenesis that also accumulated viral membranes retaining the D13 scaffold. We concluded that I2 is required for virion morphogenesis, release of the D13 scaffold, and the association of EFC proteins with viral membranes.IMPORTANCE Poxviruses comprise a large family that infect vertebrates and invertebrates, cause disease in both in humans and in wild and domesticated animals, and are being engineered as vectors for vaccines and cancer therapy. In addition, investigations of poxviruses have provided insights into many aspects of cell biology. The I2 protein is conserved in all poxviruses that infect vertebrates, suggesting an important role. The present study revealed that this protein is essential for vaccinia virus morphogenesis and that its absence results in an accumulation of deformed virus particles retaining the scaffold protein and deficient in surface proteins needed for cell entry.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  complementing cell; deletion mutant; electron microscopy; mutant virus; poxviruses; virus assembly

Mesh:

Substances:

Year:  2017        PMID: 28490596      PMCID: PMC5512257          DOI: 10.1128/JVI.00558-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Poxvirus multiprotein entry-fusion complex.

Authors:  Tatiana G Senkevich; Suany Ojeda; Alan Townsley; Gretchen E Nelson; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-08       Impact factor: 11.205

2.  Protein composition of the vaccinia virus mature virion.

Authors:  Wolfgang Resch; Kim K Hixson; Ronald J Moore; Mary S Lipton; Bernard Moss
Journal:  Virology       Date:  2006-09-26       Impact factor: 3.616

3.  Vaccinia virus H7 protein contributes to the formation of crescent membrane precursors of immature virions.

Authors:  P S Satheshkumar; Andrea Weisberg; Bernard Moss
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

4.  Participation of vaccinia virus l2 protein in the formation of crescent membranes and immature virions.

Authors:  Liliana Maruri-Avidal; Arban Domi; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

5.  Analysis of viral membranes formed in cells infected by a vaccinia virus L2-deletion mutant suggests their origin from the endoplasmic reticulum.

Authors:  Liliana Maruri-Avidal; Andrea S Weisberg; Himani Bisht; Bernard Moss
Journal:  J Virol       Date:  2012-11-28       Impact factor: 5.103

6.  Preparation of Cell Cultures and Vaccinia Virus Stocks.

Authors:  Catherine A Cotter; Patricia L Earl; Linda S Wyatt; Bernard Moss
Journal:  Curr Protoc Mol Biol       Date:  2017-01-05

7.  Vaccinia virus A21 virion membrane protein is required for cell entry and fusion.

Authors:  Alan C Townsley; Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

8.  Assembly of vaccinia virus: effects of rifampin on the intracellular distribution of viral protein p65.

Authors:  B Sodeik; G Griffiths; M Ericsson; B Moss; R W Doms
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

9.  A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies.

Authors:  E J Wolffe; S Vijaya; B Moss
Journal:  Virology       Date:  1995-08-01       Impact factor: 3.616

10.  Deep-etch EM reveals that the early poxvirus envelope is a single membrane bilayer stabilized by a geodetic "honeycomb" surface coat.

Authors:  John Heuser
Journal:  J Cell Biol       Date:  2005-04-25       Impact factor: 10.539

View more
  2 in total

1.  Vaccinia Virus C9 Ankyrin Repeat/F-Box Protein Is a Newly Identified Antagonist of the Type I Interferon-Induced Antiviral State.

Authors:  Ruikang Liu; Bernard Moss
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

2.  Vaccinia Virus Ankyrin-Repeat/F-Box Protein Targets Interferon-Induced IFITs for Proteasomal Degradation.

Authors:  Ruikang Liu; Lisa R Olano; Yeva Mirzakhanyan; Paul D Gershon; Bernard Moss
Journal:  Cell Rep       Date:  2019-10-22       Impact factor: 9.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.